Find an Article

Filter articles

Showing 121 to 130 of 731 results

IP and personalised medicine: a tailor-made approach


While personalised medicine is a challenging area for drug developers, there are a number of potential solutions, as LSIPR finds out.

3Scan’s Nada Rastad: crossing the line and patenting robotics


American biotech 3Scan is combining robotics with machine learning and automation to offer microscopy services for the 3D analysis of cells, tissues, and organs. LSIPR met general counsel Nada Rastad to hear about some of the patenting challenges.

CRISPR patents: guidance from US courts

US19-09-2018Pat Carson and Mira Atanassova Mulvaney

Several recent cases from the US Court of Appeals for the Federal Circuit offer guidance on navigating the §101 legal framework with respect to CRISPR patent claims, as Pat Carson and Mira Atanassova Mulvaney of Kirkland & Ellis report.

Conference preview: LSX World Congress USA 2018


Held in the US life sciences hub of Boston, LSX World Congress USA is bringing together investors and executive leaders from life sciences companies on October 10 and 11, as LSIPR finds out.

Patenting polymorphs in Mexico

Mexico11-09-2018Lino Almazan-Monroy and Mariana Gonzalez-Vargas

Lino Almazan-Monroy and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril discuss how inventors seeking patents for polymorphs in Mexico can give themselves the best chance of success.

Boehringer v Teva: Italian court clarifies boundaries of Bolar privilege

Italy11-09-2018Gabriel Cuonzo and Luca Pellicciari

The Milan Court has issued an important ruling clarifying the rules governing the activities of active pharmaceutical ingredient manufacturers in Italy, as Gabriel Cuonzo and Luca Pellicciari of Trevisan & Cuonzo report.

Mexico’s patent linkage system: current state, effects and flaws

Mexico06-09-2018Mariana Gonzalez-Vargas and Hector Chagoya

A well-functioning linkage system for patents and drugs allows healthcare and patent authorities to maximise the impact of innovation, say Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril, who report on the Mexican landscape.

LSIPR 50 2018: Robert Nelsen


Stephen Knight was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Patenting microorganisms in Mexico

Mexico05-09-2018Mariana Gonzalez-Vargas

Mexico has international depositary authority (IDA) status under the Budapest Treaty, which speeds up the patent process for microorganisms. Mariana Gonzalez-Vargas of Becerril, Coca & Becerril reviews the impact of the IDA on biotech patents in the country.

Medtech M&A: integration is key


As the tide of M&A activity continues to rise across the life sciences industry, LSIPR speaks to Tracy MacNeal of Ximedica on what’s driving the trend and the pitfalls to be aware of.

Showing 121 to 130 of 731 results